Ophthalmological phenotype associated with biallelic CPAMD8 variants: first report in Mexican patients.

Ophthalmic GenetMar 31, 2026 (epub)

David Apam-Garduño, Cristina Villanueva-Mendoza, Carolina Prado-Larrea et al.

✦ AI-curated · Sources linked

Case in brief

Two unrelated Mexican patients with anterior segment dysgenesis had bilateral iris hypoplasia, ectropion uveae, zonular anomalies, and secondary childhood glaucoma. Whole-exome sequencing identified novel biallelic CPAMD8 variants: one patient had a homozygous c.367_388dup variant, while the other had compound heterozygous c.2276+1G>A and c.4478T>A variants. The report associated these findings with a CPAMD8-related ocular phenotype that includes developmental anterior segment abnormalities and childhood glaucoma.

What made this case unusual

The report documents this CPAMD8-associated phenotype in Mexican patients and identifies three novel variants across the two unrelated cases.

Diagnostic / clinical pearl

Consider CPAMD8 analysis in patients with anterior segment dysgenesis or secondary childhood glaucoma accompanied by non-acquired ocular anomalies such as iris hypoplasia or zonular abnormalities.

Source

Published in Ophthalmic Genet. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Ophthalmology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.